Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III knee trial.

“His advice continues to resonate in my mind every day,” Naccarato wrote on Thursday in a reflection he shared with The Wichita Eagle. “Rusty is certainly among the best teachers, coaches, ...

Nearly three decades after the final episode of his beloved TV show aired, the Science Guy hasn’t lost his way. In fact, in ...

An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...

The Longitude Prize on ALS is offering £7.5 million to encourage scientists to use AI to speed up the search for new treatments.

High-dose dazucorilant patients who went into the open-label extension saw an 84% lower risk of death over those who didn't take it at all..

Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness ...

A local family that has a rare form of Amyotrophic Lateral Sclerosis (ALS), or sometimes referred to as Lou Gehrig’s disease, is continuing to fight and research ...

A scientist in Moose Jaw, Sask., claims he has discovered the secret to stopping the progression of ALS. His claims have attracted the attention of desperate patients and the scrutiny of ...

The research, published in Brain, highlights how digitising tests designed to measure the progression of motor symptoms in people with Huntington's disease can provide a sensitive and reliable way ...